Início/Ações/KMDA

KMDA

USD

Kamada Ltd. Ordinary Shares

$6.950+0.000 (0.000%)

Preço em tempo real

Healthcare

Drug Manufacturers - Specialty & Generic

Israel

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado

Fundamentos da empresa

Estatísticas de negociação

Métricas de mercado

Abertura

$6.950

Máximo

$7.090

Mínimo

$6.930

Volume

0.06M

Fundamentos da empresa

Capitalização de mercado

403.0M

Setor

Drug Manufacturers - Specialty & Generic

País

Israel

Estatísticas de negociação

Volume médio

0.09M

Bolsa de valores

NMS

Moeda

USD

Faixa de 52 semanas

Mínimo $4.74Atual $6.950Máximo $9.15

Notícias relacionadas

15/05/2025 · 14:39

Analyst Upgrades

Benchmark Reiterates Buy on Kamada, Maintains $15 Price Target

Benchmark analyst Robert Wasserman reiterates Kamada with a Buy and maintains $15 price target.

Ver mais

Benchmark Reiterates Buy on Kamada, Maintains $15 Price Target

7/05/2025 · 11:00

GlobeNewswire

Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025

REHOVOT, Israel, and HOBOKEN, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ:KMDA, TASE: KMDA.TA)), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for

Ver mais

Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025

5/05/2025 · 11:00

GlobeNewswire

Kamada Announces Launch of a Comprehensive Post-Marketing Research Program for CYTOGAM®

Program Aimed at Generating Key Data in Support of the Benefits of CYTOGAM® in the Management of Cytomegalovirus (CMV) in Solid Organ TransplantationA Total of 10 Studies will be Conducted in Collaboration with

Ver mais